Opinion · 25 Jun 2026
Conference abstractPublished 3 Nov 2014
CEPP regimen (Cyclophosphamide, Etoposide, Procarbazine and Prednisone) as initial treatment for Hodgkin lymphoma patients presenting with severe abnormal liver function
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
ABVD regimen (doxorubicin, bleomycin, vinblastine and dacarbazine) remains the most commonly used front-line therapy for Hodgkin lymphoma. However, atypical and extranodal presentations present challenges to initial therapy, especially in the presence of renal and liver failure. We hereby present two cases of young male patients with atypical presentation of Hodgkin lymphoma with severe abnormal liver function. Since liver toxicity is a major adverse effect for doxorubicin, doxorubicincontaining regimens are less desired for this group of patients. Patients showed excellent response to cyclophosphamide, etoposide, procarbazine and prednisone (CEPP regimen).
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Translational Medicine.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalTranslational Medicine
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Keyur Thakar”
- BylineArticles whose byline prints “Aileen Novero”
- BylineArticles whose byline prints “Arundhati Das”
- BylineArticles whose byline prints “Adriana Lisinschi”
- BylineArticles whose byline prints “Bella Mehta”
- BylineArticles whose byline prints “Tauseef Ahmed”
- BylineArticles whose byline prints “Delong Liu”
